• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GALNT2 通过 AXL 促进结直肠癌细胞的侵袭。

GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL.

机构信息

Graduate Institute of Anatomy and Cell Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.

Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Mol Oncol. 2023 Jan;17(1):119-133. doi: 10.1002/1878-0261.13347. Epub 2022 Dec 5.

DOI:10.1002/1878-0261.13347
PMID:36409270
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9812829/
Abstract

GalNAc-type O-glycosylation and its initiating GalNAc transferases (GALNTs) play crucial roles in a wide range of cellular behaviors. Among 20 GALNT members, GALNT2 is consistently associated with poor survival of patients with colorectal cancer in public databases. However, its clinicopathological significance in colorectal cancer remains unclear. In this study, immunohistochemistry showed that GALNT2 was overexpressed in colorectal tumors compared with the adjacent nontumor tissues. GALNT2 overexpression was associated with poor survival of colorectal cancer patients. Forced expression of GALNT2 promoted migration and invasion as well as peritoneal metastasis of colorectal cancer cells. In contrast, GALNT2 knockdown with siRNAs or knockout with CRISPR/Cas9 system suppressed these malignant properties. Interestingly, we found that GALNT2 modified O-glycans on AXL and determined AXL levels via the proteasome-dependent pathway. In addition, the GALNT2-promoted invasiveness was significantly reversed by AXL siRNAs. These findings suggest that GALNT2 promotes colorectal cancer invasion at least partly through AXL.

摘要

GalNAc 型 O-糖基化及其起始 GalNAc 转移酶 (GALNTs) 在广泛的细胞行为中起着至关重要的作用。在 20 种 GALNT 成员中,GALNT2 在公共数据库中与结直肠癌患者的不良生存始终相关。然而,其在结直肠癌中的临床病理意义尚不清楚。在这项研究中,免疫组织化学显示,与相邻非肿瘤组织相比,GALNT2 在结直肠肿瘤中过表达。GALNT2 的过表达与结直肠癌患者的不良生存相关。过表达 GALNT2 可促进结直肠癌细胞的迁移和侵袭以及腹膜转移。相比之下,用 siRNAs 敲低 GALNT2 或用 CRISPR/Cas9 系统敲除 GALNT2 可抑制这些恶性特性。有趣的是,我们发现 GALNT2 修饰了 AXL 上的 O-聚糖,并通过蛋白酶体依赖性途径确定了 AXL 的水平。此外,AXL siRNAs 显著逆转了 GALNT2 促进的侵袭性。这些发现表明,GALNT2 至少部分通过 AXL 促进结直肠癌的侵袭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/9a3755536500/MOL2-17-119-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/eb60b2bbc26e/MOL2-17-119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/b0c54b2c85af/MOL2-17-119-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/85ffd03292a7/MOL2-17-119-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/199469535618/MOL2-17-119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/88def1bfb68a/MOL2-17-119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/9a3755536500/MOL2-17-119-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/eb60b2bbc26e/MOL2-17-119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/b0c54b2c85af/MOL2-17-119-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/85ffd03292a7/MOL2-17-119-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/199469535618/MOL2-17-119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/88def1bfb68a/MOL2-17-119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f2b/9812829/9a3755536500/MOL2-17-119-g007.jpg

相似文献

1
GALNT2 promotes invasiveness of colorectal cancer cells partly through AXL.GALNT2 通过 AXL 促进结直肠癌细胞的侵袭。
Mol Oncol. 2023 Jan;17(1):119-133. doi: 10.1002/1878-0261.13347. Epub 2022 Dec 5.
2
GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.GALNT2通过调节表皮生长因子受体(EGFR)的糖基化和活性来增强口腔鳞状细胞癌的迁移和侵袭能力。
Oral Oncol. 2014 May;50(5):478-84. doi: 10.1016/j.oraloncology.2014.02.003. Epub 2014 Feb 28.
3
Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.黏蛋白糖基化酶 GALNT2 通过修饰表皮生长因子受体调节肝癌的恶性特征。
Cancer Res. 2011 Dec 1;71(23):7270-9. doi: 10.1158/0008-5472.CAN-11-1161. Epub 2011 Oct 11.
4
The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer.O-糖基化酶 GALNT2 在非小细胞肺癌中作为致癌驱动因子发挥作用。
Cell Mol Biol Lett. 2022 Sep 4;27(1):71. doi: 10.1186/s11658-022-00378-w.
5
Expression of GALNT2 in human extravillous trophoblasts and its suppressive role in trophoblast invasion.GALNT2 在人绒毛外滋养细胞中的表达及其对滋养细胞侵袭的抑制作用。
Placenta. 2012 Dec;33(12):1005-11. doi: 10.1016/j.placenta.2012.08.007. Epub 2012 Oct 30.
6
GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.GALNT2通过胰岛素样生长因子-1受体抑制恶性表型,并预测神经母细胞瘤的预后良好。
Oncotarget. 2014 Dec 15;5(23):12247-59. doi: 10.18632/oncotarget.2627.
7
GALNT2 promotes cell proliferation, migration, and invasion by activating the Notch/Hes1-PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma.GALNT2 通过激活 Notch/Hes1-PTEN-PI3K/Akt 信号通路促进肺腺癌细胞增殖、迁移和侵袭。
Life Sci. 2021 Jul 1;276:119439. doi: 10.1016/j.lfs.2021.119439. Epub 2021 Mar 27.
8
Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer.髓样锌指蛋白 1 通过 Axl 基因表达诱导实体瘤中的迁移、侵袭和体内转移。
Mol Cancer Res. 2010 Feb;8(2):159-69. doi: 10.1158/1541-7786.MCR-09-0326. Epub 2010 Feb 9.
9
The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities.O-糖基化酶GALNT2通过降低表皮生长因子受体(EGFR)的活性来抑制胃腺癌的恶性程度。
Am J Cancer Res. 2018 Sep 1;8(9):1739-1751. eCollection 2018.
10
Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.黏蛋白 O-糖基转移酶 GALNT2 通过激活 EGFR/PI3K/Akt/mTOR 轴促进神经胶质瘤的恶性特征。
Clin Sci (Lond). 2019 May 21;133(10):1167-1184. doi: 10.1042/CS20190145. Print 2019 May 31.

引用本文的文献

1
Integrating Bulk RNA and Single-cell transcriptome to explore the role of glycan-related genes in lung adenocarcinoma.整合批量RNA和单细胞转录组以探究聚糖相关基因在肺腺癌中的作用。
J Cancer. 2025 Jul 24;16(11):3314-3328. doi: 10.7150/jca.115989. eCollection 2025.
2
Therapeutic gene targets and epigenetic modifications in rheumatoid arthritis: Insights from MTX, JAK inhibitors, and LLDT-8.类风湿关节炎中的治疗性基因靶点和表观遗传修饰:来自甲氨蝶呤、JAK抑制剂和LLDT-8的见解
Biochem Biophys Rep. 2025 May 5;42:102038. doi: 10.1016/j.bbrep.2025.102038. eCollection 2025 Jun.
3
The role of glycan-lectin interactions in the tumor microenvironment: immunosuppression regulators of colorectal cancer.

本文引用的文献

1
D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1.D-甘露糖通过降解 PD-L1 促进三阴性乳腺癌的免疫治疗和放疗。
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8). doi: 10.1073/pnas.2114851119.
2
AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis.AXL受体酪氨酸激酶作为一个有前景的治疗靶点,主导癌症进展和转移的多个方面。
Cancers (Basel). 2022 Jan 18;14(3):466. doi: 10.3390/cancers14030466.
3
Proteome biology of primary colorectal carcinoma and corresponding liver metastases.
聚糖-凝集素相互作用在肿瘤微环境中的作用:结直肠癌的免疫抑制调节因子
Am J Cancer Res. 2025 Apr 15;15(4):1347-1383. doi: 10.62347/WBJL4045. eCollection 2025.
4
Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarcinoma.致癌性 GALNT5 通过激活胰腺导管腺癌中的 MYH9/NOTCH/DDR 轴赋予 FOLFIRINOX 耐药性。
Cell Death Dis. 2024 Oct 21;15(10):767. doi: 10.1038/s41419-024-07110-w.
5
Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression.ST6GALNAC1 和 ST6GALNAC2 的差异表达及其与结直肠癌进展的临床相关性。
PLoS One. 2024 Sep 30;19(9):e0311212. doi: 10.1371/journal.pone.0311212. eCollection 2024.
6
Integrative single-cell analysis of LUAD: elucidating immune cell dynamics and prognostic modeling based on exhausted CD8+ T cells.LUAD 的综合单细胞分析:基于耗竭的 CD8+ T 细胞阐明免疫细胞动力学和预后建模。
Front Immunol. 2024 Mar 26;15:1366096. doi: 10.3389/fimmu.2024.1366096. eCollection 2024.
7
Metabolic Signaling in Cancer Metastasis.癌症转移中的代谢信号。
Cancer Discov. 2024 Jun 3;14(6):934-952. doi: 10.1158/2159-8290.CD-24-0174.
8
GALNT2 targeted by miR-139-5p promotes proliferation of clear cell renal cell carcinoma via inhibition of LATS2 activation.受miR-139-5p靶向的GALNT2通过抑制LATS2激活促进肾透明细胞癌增殖。
Discov Oncol. 2024 Mar 13;15(1):73. doi: 10.1007/s12672-024-00930-4.
9
GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A.GALNT12 通过 BMPR1A 的 O-糖基化激活 BMP 通路来抑制骨特异性前列腺癌转移。
Int J Biol Sci. 2024 Jan 27;20(4):1297-1313. doi: 10.7150/ijbs.91925. eCollection 2024.
10
GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization.GALNT12通过加速YAP1核定位促进纤维肉瘤生长。
Oncol Lett. 2023 Nov 3;26(6):543. doi: 10.3892/ol.2023.14131. eCollection 2023 Dec.
原发性结直肠癌及其肝转移的蛋白质组生物学。
Neoplasia. 2021 Dec;23(12):1240-1251. doi: 10.1016/j.neo.2021.10.005. Epub 2021 Nov 9.
4
AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer.AXL 抑制剂 TP-0903 降低胰腺癌的转移和治疗抵抗。
Mol Cancer Ther. 2022 Jan;21(1):38-47. doi: 10.1158/1535-7163.MCT-21-0293. Epub 2021 Oct 21.
5
AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer.AXL是RAS野生型转移性结直肠癌患者生存预后不良及抗表皮生长因子受体(EGFR)治疗耐药的一个预测指标。
Eur J Cancer. 2020 Oct;138:1-10. doi: 10.1016/j.ejca.2020.07.010. Epub 2020 Aug 17.
6
C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.C1GALT1 与不良预后相关,并通过激活胃癌中的 Ephrin A1 介导的细胞迁移 EPHA2 促进可溶性 Ephrin A1 的迁移。
Oncogene. 2020 Mar;39(13):2724-2740. doi: 10.1038/s41388-020-1178-7. Epub 2020 Jan 31.
7
T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form.T618I CSF3R 突变在慢性中性粒细胞白血病中通过异常转运和糖基化受体形式的组成性磷酸化诱导致癌信号。
Biochem Biophys Res Commun. 2020 Feb 26;523(1):208-213. doi: 10.1016/j.bbrc.2019.12.030. Epub 2019 Dec 14.
8
TAM receptors, Phosphatidylserine, inflammation, and Cancer.TAM 受体、磷脂酰丝氨酸、炎症与癌症。
Cell Commun Signal. 2019 Nov 27;17(1):156. doi: 10.1186/s12964-019-0461-0.
9
Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.黏蛋白 O-糖基转移酶 GALNT2 通过激活 EGFR/PI3K/Akt/mTOR 轴促进神经胶质瘤的恶性特征。
Clin Sci (Lond). 2019 May 21;133(10):1167-1184. doi: 10.1042/CS20190145. Print 2019 May 31.
10
Polypeptide GalNAc-Ts: from redundancy to specificity.糖基转移酶多肽 GalNAc-Ts:从冗余到特异性。
Curr Opin Struct Biol. 2019 Jun;56:87-96. doi: 10.1016/j.sbi.2018.12.007. Epub 2019 Jan 28.